Performance
(as of 03/31/2022)
| As of 3/31/2022 | QTD | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Inception | Fact Sheet | Commentary | |
|---|---|---|---|---|---|---|---|---|---|---|
| Riverbridge Mid Cap Growth | Gross | -13.88% | -13.88% | -4.83% | 16.12% | 15.36% | 0.00% | 11.87% |  | |
| Net | -14.09% | -14.09% | -5.60% | 15.50% | 14.75% | 0.00% | 11.30% | |||
| Russell Midcap® Growth | -12.58% | -12.58% | -0.89% | 14.81% | 15.10% | 0.00% | 12.14% |
Periods greater than one year are annualized. Inception Date: 06/30/2014. The above information is supplemental to the GIPS® Report. Please refer to the GIPS Report and Riverbridge Disclosures.
Overview
The Riverbridge Mid Cap Growth Portfolio was established in 2014. It is a diversified growth stock portfolio invested in 40-55 companies of mid market capitalization size. Due to our long-term investment approach, turnover for the portfolio is low. The portfolio is managed by the Riverbridge Investment Team utilizing our time-tested investment philosophy and disciplines.
Investment Philosophy
Riverbridge believes earnings power determines the value of a business, therefore we invest in high quality growth companies that possess the ability to build their earnings power at above-average rates for long periods of time. We define earnings power as companies achieving high returns on invested capital while possessing an enduring strategic advantage in their marketplace. We build portfolios by identifying and buying well-managed companies we believe can maintain consistent unit growth and strong free cash flow, allowing them to finance their growth using internally generated sources of capital.
Sector Weightings
Portfolio Facts
(as of 03/31/2022)
| Inception Year | 2014 |
| Number of Holdings | 43 |
| Wgt. Avg. Market Cap | $19.0 billion |
| 5-Year Turnover | 16.70% |
| Investment Vehicles | Separate Account |
Top 10 Holdings
(as of 03/31/2022)
| Bio-Techne Corporation | 4.53% |
| Tyler Technologies, Inc. | 4.27% |
| Ansys, Inc. | 4.15% |
| Fastenal Company | 4.14% |
| Verisk Analytics, Inc. | 4.12% |
| West Pharmaceutical Services, Inc. | 3.94% |
| Zscaler, Inc. | 3.79% |
| Five Below, Inc. | 3.31% |
| Amedisys, Inc. | 3.30% |
| HEICO Corporation | 3.08% |
| TOTAL | 38.64% |
